Hilado Maria Teresa 4

What Happened Maria Teresa Hilado, a director of Zimmer Biomet Holdings, Inc. (ZBH), was awarded 378.873 phantom stock units on 2026-03-31. The units were granted at $0.00 (an award, not a purchase), are derivative in nature (phantom units), and show $0 acquisition price on the Form 4.

Key Details

• Transaction date: 2026-03-31; Form 4 filed 2026-04-02.
• Security: 378.873 phantom stock units (derivative); reported price $0.00 (transaction code A = award/grant).
• Conversion/exercise: 1-for-1 (F2).
• Settlement: Units are to be settled in cash in ten annual installments beginning within 60 days after the end of the calendar year in which the director’s service ends (F3).
• Dividend reinvestment: 30.381 of the units were accrued on 2026-01-30 under the plan’s dividend reinvestment provision (F4).
• Shares/units held after the transaction: not specified on this filing.
• Filing status: Form was filed on 2026-04-02 (no late‑filing flag shown in the provided data).

Context These are phantom (cash‑settled) units granted under the Zimmer Biomet Deferred Compensation Plan for Non‑Employee Directors (F1). Phantom units are derivative awards that do not represent current stock ownership and will be paid in cash per the schedule above, so this award is a compensation event rather than an outright equity purchase by the director.